Učitavanje...
Feasibility of Aerosolized Alpha-1 Antitrypsin as a Therapeutic Option
Inhalation therapy is integral in the management of patients with chronic obstructive pulmonary disease (COPD). Specifically, intravenous augmentation therapy is available to patients with alpha-1 antitrypsin deficiency (AATD), although there is insufficient alpha-1 antitrypsin (AAT) delivery to the...
Spremljeno u:
| Izdano u: | Chronic Obstr Pulm Dis |
|---|---|
| Glavni autor: | |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
COPD Foundation Inc
2020
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7857706/ https://ncbi.nlm.nih.gov/pubmed/32726075 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15326/jcopdf.7.3.2019.0179 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|